Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Oppenheimer & Co. Fall Summit Focused on Specialty Pharma, Rare Disease & Gene Therapy
 Monday, September 23, 2019 -
Tuesday, September 24, 2019